Loading...
Loading...
HSCS| Name | Value |
|---|---|
| Revenues | 1.9K |
| Cost of Revenue | 0.8K |
| Gross Profit | 1.2K |
| Operating Expense | 1,310.5K |
| Operating I/L | -1,309.3K |
| Other Income/Expense | -32.8K |
| Interest Income | 32.8K |
| Pretax | -1,342.1K |
| Income Tax Expense | 32.8K |
| Net Income/Loss | -1,374.9K |
Heart Test Laboratories, Inc. is a medical technology company specializing in cardiovascular diagnostic devices. The company's flagship product, MyoVista wavECG, is a resting 12-lead electrocardiograph (ECG) that provides diagnostic information related to cardiac dysfunction, offering an alternative to conventional 12-lead resting ECG. Heart Test Laboratories, Inc. generates revenue by selling its innovative diagnostic devices to clinics, doctor's offices, urgent care centers, and hospitals, enabling healthcare professionals to accurately diagnose and monitor cardiac conditions.
